Zhang J - Search Results

1

Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer.

Jin Y, Chen Y, Tang H, Hu X, Hubert SM, Li Q, Su D, Xu H, Fan Y, Yu X, Chen Q, Liu J, Hong W, Xu Y, Deng H, Zhu D, Li P, Gong Y, Xia X, Gay CM, Zhang J, Chen M. Jin Y, et al. Among authors: zhang j. Clin Cancer Res. 2022 Feb 1;28(3):526-539. doi: 10.1158/1078-0432.CCR-21-1943. Epub 2021 Dec 17. Clin Cancer Res. 2022. PMID: 34921019

2

Deletion of tumor suppressor genes in Chinese non-small cell lung cancer.

An Q, Liu Y, Gao Y, Huang J, Fong X, Liu L, Zhang D, Zhang J, Cheng S. An Q, et al. Among authors: zhang d, zhang j. Cancer Lett. 2002 Oct 28;184(2):189-95. doi: 10.1016/s0304-3835(02)00204-5. Cancer Lett. 2002. PMID: 12127691

3

Identification of differentially expressed genes in immortalized human bronchial epithelial cell line as a model for in vitro study of lung carcinogenesis.

An Q, Pacyna-Gengelbach M, Schlüns K, Deutschmann N, Guo S, Gao Y, Zhang J, Cheng S, Petersen I. An Q, et al. Among authors: zhang j. Int J Cancer. 2003 Jan 10;103(2):194-204. doi: 10.1002/ijc.10807. Int J Cancer. 2003. PMID: 12455033

4

Sorafenib in non-small cell lung cancer.

Zhang J, Gold KA, Kim E. Zhang J, et al. Expert Opin Investig Drugs. 2012 Sep;21(9):1417-26. doi: 10.1517/13543784.2012.699039. Epub 2012 Jun 24. Expert Opin Investig Drugs. 2012. PMID: 22725255 Review.

5

Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry.

Zhang J, Gold KA, Lin HY, Swisher SG, Xing Y, Lee JJ, Kim ES, William WN Jr. Zhang J, et al. J Thorac Oncol. 2015 Apr;10(4):682-90. doi: 10.1097/JTO.0000000000000456. J Thorac Oncol. 2015. PMID: 25590605 Free PMC article.

6

Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.

Skoulidis F, Byers LA, Diao L, Papadimitrakopoulou VA, Tong P, Izzo J, Behrens C, Kadara H, Parra ER, Canales JR, Zhang J, Giri U, Gudikote J, Cortez MA, Yang C, Fan Y, Peyton M, Girard L, Coombes KR, Toniatti C, Heffernan TP, Choi M, Frampton GM, Miller V, Weinstein JN, Herbst RS, Wong KK, Zhang J, Sharma P, Mills GB, Hong WK, Minna JD, Allison JP, Futreal A, Wang J, Wistuba II, Heymach JV. Skoulidis F, et al. Among authors: zhang j. Cancer Discov. 2015 Aug;5(8):860-77. doi: 10.1158/2159-8290.CD-14-1236. Epub 2015 Jun 11. Cancer Discov. 2015. PMID: 26069186 Free PMC article.

7

Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.

Gomez DR, Blumenschein GR Jr, Lee JJ, Hernandez M, Ye R, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Gibbons DL, Karam JA, Kavanagh BD, Tang C, Komaki R, Louie AV, Palma DA, Tsao AS, Sepesi B, William WN, Zhang J, Shi Q, Wang XS, Swisher SG, Heymach JV. Gomez DR, et al. Among authors: zhang j. Lancet Oncol. 2016 Dec;17(12):1672-1682. doi: 10.1016/S1470-2045(16)30532-0. Epub 2016 Oct 24. Lancet Oncol. 2016. PMID: 27789196 Free PMC article. Clinical Trial.

8

Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.

Reddy JP, Tang C, Shih T, Kim B, Kim C, Nguyen QN, Welsh J, Benveniste M, Zhang J, Liao Z, Gomez DR. Reddy JP, et al. Among authors: zhang j. Clin Lung Cancer. 2017 Mar;18(2):141-148. doi: 10.1016/j.cllc.2016.11.003. Epub 2016 Nov 10. Clin Lung Cancer. 2017. PMID: 27913215 Free PMC article.

9

Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma.

Sivakumar S, Lucas FAS, McDowell TL, Lang W, Xu L, Fujimoto J, Zhang J, Futreal PA, Fukuoka J, Yatabe Y, Dubinett SM, Spira AE, Fowler J, Hawk ET, Wistuba II, Scheet P, Kadara H. Sivakumar S, et al. Among authors: zhang j. Cancer Res. 2017 Nov 15;77(22):6119-6130. doi: 10.1158/0008-5472.CAN-17-1605. Epub 2017 Sep 26. Cancer Res. 2017. PMID: 28951454 Free PMC article.

10

Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer.

Schvartsman G, Peng SA, Bis G, Lee JJ, Benveniste MFK, Zhang J, Roarty EB, Lacerda L, Swisher S, Heymach JV, Fossella FV, William WN. Schvartsman G, et al. Among authors: zhang j. Lung Cancer. 2017 Oct;112:90-95. doi: 10.1016/j.lungcan.2017.07.034. Epub 2017 Aug 3. Lung Cancer. 2017. PMID: 29191606

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179,240 results

Search Page

Filters